CereMetrix Corp. Introduces Enhancements to its Advanced Medical Imaging and Analytics Platform
CereMetrix 2.0 leverages the platform’s quantitative SPECT imaging and reporting capabilities to accommodate a broader range of modality agnostic clinical and research applications. Read Press Release
CereHealth Corporation Granted Patent for Composite Average and Clustering Technique
CereHealth Corporation has been granted a 3rd patent on its novel medical imaging and data analytics technology. Read Press Release
CereHealth Welcomes New Members to its Scientific and Medical Advisory Board
CereHealth has assembled an expert team of business, scientific and medical advisors in pursuit of worldwide market penetration for its browser-based, cloud-enabled imaging and data analytics platforms, as it welcomes Drs. James Chomas and Ty Vachon. Read Press Release
Precision Medicine: The Race to Integrate AI and Big Data Technologies Into Clinical Care Has Never Been More Important
An aging population worldwide with the associated prevalence of chronic diseases and late-life disabilities mandates greater emphasis on use of precision medicine in the clinical setting In 2015, when the Obama Administration announced the Precision Medicine Initiative, a research effort to revolutionize health and disease treatment, it heralded a shift in the traditional “one-size-fits-all” approach […]
Going against the norm: validation of a novel alternative to brain SPECT normative datasets
A New Frontier for Medicine: CereHealth’s validation of their novel alternative to brain SPECT quantification We invited a noted Radiologist, Dr. Cyrus Raji, to work with our Senior Medical Imaging Engineer, Lindsay Quandt, to explore our unique methodology and how it compares to use of normative datasets. Their analysis and findings are now available online […]
AD’s Heterogeneous Nature
AD’s Heterogeneous Nature John Kelley, Chairman and CEO of CereHealth Corp, was a featured speaker at a Digital Pathology & Precision Medicine Symposium on September 4, 2020, which was hosted by Dr. Rhoda Au, Professor of Anatomy & Neurobiology, Neurology, and Epidemiology at Boston University’s School of Medicine. The conference was organized by Oxford Global […]
Going Against the Norm
Seeing is Believing Every day, CereMetrix™ plays a pivotal role in brain diagnostics by improving radiological insight and streamlining clinical practice. One of the things that sets it apart is its use of a population template, a large dataset of clinical scans, to help radiologists identify atypical perfusion patterns. This FDA-approved quantification method helps radiologists […]
Graphs & COVID-19
As COVID-19 consumes our attention, I couldn’t help but notice all of the ways this pandemic exemplifies the concepts CereMetrix is harnessing today. Our up-and-coming product, illumeai, is powered by graphs: data that is represented by objects and their relationships. With COVID-19, perhaps the easiest way to think about this is in terms of its […]
Going Against the Norm: A Novel Alternative to Normative Datasets for Clinical Brain SPECT
Lindsay M. Quandt1* and Cyrus A. Raji2 1CereHealth Corporation, Littleton, Colorado, 80120, USA 2Mallinckrodt Institute of Technology, Washington University in St. Louis, St. Louis, Missouri, 63110, USA Abstract Aim: Quantitative analysis of brain SPECT perfusion imaging is dependent on comparison to normative datasets that are challenging to produce. This study investigated the combination of […]
